Which entity is directed to combat fraud and abuse in the healthcare industry under HIPAA?

The entity that is specifically directed to combat fraud and abuse in the healthcare industry under the Health Insurance Portability and Accountability Act (HIPAA) is the Office of Inspector General (OIG). The OIG plays a crucial role in protecting the integrity of healthcare programs and the health and welfare of beneficiaries by preventing, detecting, and investigating fraud and abuse within these programs. Its functions include conducting audits, evaluations, and investigations in order to ensure compliance with regulations and to promote the overall efficiency of healthcare services.

The OIG also works alongside various healthcare organizations and providers to develop compliance programs that help to identify and mitigate risks related to fraud and abuse. This oversight is essential for maintaining the trust and safety of the healthcare system, ensuring that resources are used appropriately, and protecting patient information as mandated by HIPAA.

In contrast, the other entities mentioned have different focuses: the Centers for Medicare & Medicaid Services (CMS) oversees the administration of major healthcare programs but does not focus exclusively on fraud; the Food and Drug Administration (FDA) is concerned with the regulation of food and drugs rather than healthcare fraud; and the National Provider Identifier (NPI) is simply a unique identification number for healthcare providers, not an agency focused on combating fraud.